News

Wednesday January 22, 2020

Destiny Pharma to attend 4th AMR Conference: Novel Antimicrobials and AMR Diagnostics, 1...

Destiny Pharma is attending the 4th AMR Conference: Novel Antimicrobials and AMR Diagnostics on 12 – 13 March 2020, in Basel, Switzerland If you would like to meet with Destiny Pharma, […]

Wednesday January 22, 2020

Destiny Pharma to attend Infection Control 2020, 13 February 2020, Birmingham, UK

Destiny Pharma is attending the Infection Control 2020 conference on 13 February 2020, in Birmingham, UK If you would like to meet with Destiny Pharma, please email us on conferences@destinypharma.com

Wednesday January 22, 2020

22 Jan 2020 – Proactive interview – Destiny Pharma awaits key inflection poi...

Destiny Pharma CEO, Neil Clark, spoke with Proactive at the Biotech Showcase 2020 in San Francisco.  Please click here for video.

Monday January 20, 2020

20 Jan 2020 – Positive update on the development of new XF-platform drug formulati...

Collaboration with MedPharm Ltd. delivers data profiling new XF‐platform drug formulations as potential treatments for dermal and ocular infections. New formulations support a growing pipeline alongside lead drug asset, XF-73, […]

Tuesday January 7, 2020

Destiny Pharma to present at LSX World Congress 2020, 4th February 2020, London, UK

Destiny Pharma is presenting at the LSX World Congress 2020 on 4 February 2020, in London, UK If you would like to meet with Destiny Pharma, please email us on conferences@destinypharma.com